| Document Date: 2014-11-25 12:02:47
Open Document File Size: 160,29 KBShare Result on Facebook
City LAKE FOREST / / Company IMMEDIATE RELEASE HOSPIRA ISSUES A VOLUNTARY NATIONWIDE / Hospira Inc. / HOSPIRA ISSUES A VOLUNTARY NATIONWIDE / Stericycle / / / Event Product Issues / Product Recall / / / IndustryTerm manufacturing glass defect / Replacement product / healthcare costs / infusion technologies / / MedicalCondition thrombophlebitis / shortness of breath / local inflammation / nausea / fever / pain / vomiting / cardiac and renal disease / macrovascular disease / tachycardia / / MedicalTreatment surgery / / Organization U.S. Food and Drug Administration / / Person LOT OF METOCLOPRAMIDE / / / Product This / VOLUNTARY NATIONWIDE / METOCLOPRAMIDE / ONDANSETRON / lot of Metoclopramide Injection / / ProvinceOrState Illinois / / Technology infusion technologies / / URL www.fda.gov/medwatch/report.htm / www.hospira.com / www.fda.gov/MedWatch/getforms.htm / /
SocialTag |
Hospira Issues A Voluntary Nationwide Recall of One Lot of Metoclopramide Injection, USP, and two lots of ondansetron injection, USP, due to Glass (Glass Strands) particulate caused by glass supplier defect